文献速递耳科与耳神经小儿耳鼻咽喉

遗传性耳聋的新兴疗法:精准基因编辑的崛起

Emerging Therapies for Genetic Deafness: The Rise of Precision Gene Editing.
PubMed 文献 · Ear Hear · 2026-10-13

本文综述基因编辑治疗遗传性与获得性耳聋的现状,重点总结小鼠模型中显性与隐性耳聋的关键临床前研究。文章讨论CRISPR-Cas、碱基编辑和先导编辑等技术及载体递送与给药途径的优劣,并指出编辑效率、细胞特异性靶向和向人类转化等障碍。

要点

  • 超过150个基因与耳聋相关,单基因遗传性耳聋是基因治疗的理想候选。
  • CRISPR-Cas、碱基编辑和先导编辑可在原生基因组位点精确纠正致病变异。
  • 临床前研究多在小鼠模型中进行,编辑效率与细胞特异性靶向仍是转化障碍。

核心结论

  • 基因编辑技术向变异特异性、持久且可能治愈的耳聋治疗迈出关键一步。

研究设计与样本

  • 综述,总结遗传性与获得性耳聋的基因编辑方法及小鼠模型关键临床前研究。

主要发现

  • 载体工程与基因组编辑技术进步使内耳听觉细胞的精准靶向成为可能。
  • CRISPR-Cas、碱基编辑和先导编辑可纠正原生基因组位点的致病变异。
  • 临床前研究涵盖显性与隐性遗传性耳聋的小鼠模型。

临床怎么用

  • 为耳鼻咽喉科医生理解遗传性耳聋基因治疗策略提供参考框架。
  • 提示基因编辑疗法尚处临床前阶段,需关注编辑效率与递送系统。

局限性

  • 关键证据主要来自小鼠模型,向人类转化仍面临障碍。
  • 编辑效率、细胞特异性靶向和人类转化是待解决问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hearing loss is a prevalent sensory disorder with profound social and health impacts. Although hearing aids and cochlear implants can significantly restore auditory perception, they do not address the underlying genetic causes. Inherited forms of hearing loss, often monogenic, are ideal candidates for gene therapy, particularly since over 150 genes have been linked to deafness. Advances in vector engineering and genome editing technologies now enable precise targeting of auditory cells within the inner ear. Technologies such as Clustered Regularly Interspaced Short Palindromic Repeats-Cas systems, base editing, and prime editing offer powerful tools to correct pathogenic variants at their native genomic loci. This review summarizes the current landscape of gene editing approaches for both hereditary and acquired hearing loss, emphasizing key preclinical studies in mouse models encompassing dominant and recessive forms of deafness. We discuss the advantages and limitations of different editing techniques, vector delivery systems, and administration routes, and explore obstacles including editing efficiency, cell-specific targeting, and the translation of these therapies to humans. Collectively, these advances represent a pivotal step toward variant-specific, durable, and potentially curative treatments for hearing loss.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Lahlou G, Cornille M, Lai N, et al. Emerging Therapies for Genetic Deafness: The Rise of Precision Gene Editing. Ear Hear. 2026. PMID: 42868209. doi:10.1097/AUD.0000000000001903

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。